HCV - SCH 503034 Jumps on the Fast Track

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Healthy Habits: What Your Doctor Wants You To Know
Title: Healthy Habits: What Your Doctor Wants You To KnowCategory: Doctor's ViewsCreated: 12/9/2005Last Editorial Review: 12/22/2005

Infectious Mononucleosis
Title: Infectious MononucleosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/14/2005

Vertex Progresses with VX-950
Vertex is the racehorse to watch right now. They are progressing quicky on their preliminary good results. While it's not yet time to line up for their treatment, we believe theirs will be first to market of the new approaches...